Pharmagen Stock Analysis

Pharmagen Stock Analysis Notes

The company had not issued any dividends in recent years. Pharmagen had 45:1 split on the 7th of December 2011. Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. in January 2013. PHARMAGEN INC operates under Medical Distribution classification in the United States and is traded on PNK Exchange. It employs 24 people. To find out more about Pharmagen contact the company at 204-898-8160 or learn more at https://www.pharmageninc.com.

Pharmagen Investment Alerts

Pharmagen Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 361.95 K.

Pharmagen Profitablity

The company has Profit Margin (PM) of (1.33) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.31) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.31.

Technical Drivers

As of the 20th of March, Pharmagen holds the Variance of 169.49, risk adjusted performance of (0.11), and Coefficient Of Variation of (768.11). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pharmagen, as well as the relationship between them.

Pharmagen Price Movement Analysis

Pharmagen Outstanding Bonds

Pharmagen Technical and Predictive Indicators

Pharmagen Forecast Models

Pharmagen's time-series forecasting models are one of many Pharmagen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pharmagen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pharmagen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pharmagen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pharmagen. By using and applying Pharmagen Stock analysis, traders can create a robust methodology for identifying Pharmagen entry and exit points for their positions.

When running Pharmagen's price analysis, check to measure Pharmagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagen is operating at the current time. Most of Pharmagen's value examination focuses on studying past and present price action to predict the probability of Pharmagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagen's price. Additionally, you may evaluate how the addition of Pharmagen to your portfolios can decrease your overall portfolio volatility.